GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunil Healthcare Ltd (BOM:537253) » Definitions » Cyclically Adjusted Revenue per Share

Sunil Healthcare (BOM:537253) Cyclically Adjusted Revenue per Share : ₹112.24 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sunil Healthcare Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sunil Healthcare's adjusted revenue per share for the three months ended in Dec. 2024 was ₹20.067. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹112.24 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Sunil Healthcare's average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-05-31), Sunil Healthcare's current stock price is ₹72.00. Sunil Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was ₹112.24. Sunil Healthcare's Cyclically Adjusted PS Ratio of today is 0.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sunil Healthcare was 1.67. The lowest was 0.46. And the median was 0.68.


Sunil Healthcare Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Sunil Healthcare's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunil Healthcare Cyclically Adjusted Revenue per Share Chart

Sunil Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 105.68 110.40

Sunil Healthcare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 110.52 110.40 111.76 112.69 112.24

Competitive Comparison of Sunil Healthcare's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Sunil Healthcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunil Healthcare's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunil Healthcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sunil Healthcare's Cyclically Adjusted PS Ratio falls into.


;
;

Sunil Healthcare Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sunil Healthcare's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=20.067/158.3229*158.3229
=20.067

Current CPI (Dec. 2024) = 158.3229.

Sunil Healthcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 14.796 94.103 24.894
201409 19.113 96.780 31.267
201412 19.385 96.780 31.712
201503 16.996 97.163 27.694
201506 15.921 99.841 25.247
201509 16.551 101.753 25.753
201512 24.276 102.901 37.351
201603 22.153 102.518 34.212
201606 20.424 105.961 30.517
201609 23.614 105.961 35.283
201612 27.220 105.196 40.967
201703 27.098 105.196 40.783
201803 0.000 109.786 0.000
201806 19.061 111.317 27.110
201809 21.097 115.142 29.009
201812 20.541 115.142 28.244
201903 17.974 118.202 24.075
201906 17.743 120.880 23.239
201909 16.254 123.175 20.892
201912 17.694 126.235 22.192
202003 15.159 124.705 19.246
202006 20.582 127.000 25.658
202009 22.850 130.118 27.803
202012 23.206 130.889 28.070
202103 21.617 131.771 25.973
202106 25.488 134.084 30.096
202109 29.407 135.847 34.272
202112 30.722 138.161 35.205
202203 31.197 138.822 35.579
202206 32.569 142.347 36.224
202209 29.826 144.661 32.643
202212 25.374 145.763 27.560
202303 20.670 146.865 22.283
202306 22.098 150.280 23.281
202309 23.078 151.492 24.119
202312 22.668 152.924 23.468
202403 20.829 153.035 21.549
202406 20.833 155.789 21.172
202409 19.582 157.882 19.637
202412 20.067 158.323 20.067

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Sunil Healthcare  (BOM:537253) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sunil Healthcare's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=72.00/112.24
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sunil Healthcare was 1.67. The lowest was 0.46. And the median was 0.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sunil Healthcare Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sunil Healthcare's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunil Healthcare Business Description

Industry
Traded in Other Exchanges
N/A
Address
38E/252 - A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment that is Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of revenue from India.

Sunil Healthcare Headlines

No Headlines